Stock Research for ACAD

ACAD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ACAD Stock Chart & Research Data

The ACAD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACAD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACAD Due diligence Resources & Stock Charts

The ACAD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACAD Detailed Price Forecast - CNN Money CNN View ACAD Detailed Summary - Google Finance
Yahoo View ACAD Detailed Summary - Yahoo! Finance Zacks View ACAD Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ACAD Trends & Analysis - Trade-Ideas Barrons View ACAD Major Holders - Barrons
NASDAQ View ACAD Call Transcripts - NASDAQ Seeking View ACAD Breaking News & Analysis - Seeking Alpha
Spotlight View ACAD Annual Report - CompanySpotlight.com OTC Report View ACAD OTC Short Report - OTCShortReport.com
TradeKing View ACAD Fundamentals - TradeKing Charts View ACAD SEC Filings - Bar Chart
WSJ View Historical Prices for ACAD - The WSJ Morningstar View Performance/Total Return for ACAD - Morningstar
MarketWatch View the Analyst Estimates for ACAD - MarketWatch CNBC View the Earnings History for ACAD - CNBC
StockMarketWatch View the ACAD Earnings - StockMarketWatch MacroAxis View ACAD Buy or Sell Recommendations - MacroAxis
Bullish View the ACAD Bullish Patterns - American Bulls Short Pains View ACAD Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ACAD Stock Mentions - StockTwits PennyStocks View ACAD Stock Mentions - PennyStockTweets
Twitter View ACAD Stock Mentions - Twitter Invest Hub View ACAD Investment Forum News - Investor Hub
Yahoo View ACAD Stock Mentions - Yahoo! Message Board Seeking Alpha View ACAD Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ACAD - SECform4.com Insider Cow View Insider Transactions for ACAD - Insider Cow
CNBC View ACAD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACAD - OTC Markets
Yahoo View Insider Transactions for ACAD - Yahoo! Finance NASDAQ View Institutional Holdings for ACAD - NASDAQ


Stock Charts

FinViz View ACAD Stock Insight & Charts - FinViz.com StockCharts View ACAD Investment Charts - StockCharts.com
BarChart View ACAD Stock Overview & Charts - BarChart Trading View View ACAD User Generated Charts - Trading View




Latest Financial News for ACAD


Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Friday April 19, 2024

SAN DIEGO, April 19, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on April 10, 2024, the Compensation Committee of Acadia’s Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common stock and 12,739 restricted stock units ("RSUs") to six new employees under Acadia’s 2023 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employme


Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Posted on Wednesday April 17, 2024

SAN DIEGO, April 17, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that two oral presentations featuring DAYBUE™ (trofinetide) findings in Rett syndrome will be presented at the American Academy of Neurology (AAN) 2024 annual meeting, being held this week in Denver, CO.


3 Pharma Stocks to Sell in April Before They Crash & Burn
Posted on Thursday April 11, 2024

There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures. Several major pharmaceutical firms are grappling with patent cliffs, where key drug exclusivities are expiring. This opens the door for generic competition. Moreover, with the broader market presenting attractive investment options, holding on to these riskier pharma plays could result in significant opportunity cost. Many pro


ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares
Posted on Tuesday April 09, 2024

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders, has reported an insider sell transaction.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.